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1272Objective: We measured lung function before and after video-assisted thoracoscopic apical bullectomy and talc
poudrage in patients with spontaneous pneumothoraces.
Methods: Seventy-two patients were prospectively followed up for 12 months. The indications for surgery
were recurrent pneumothoraces (n¼ 58), bilateral pneumothoraces (n¼ 8), and persistent air leak (n¼ 6). There
were 46 males and 26 females with mean age of 29 years (range 15–61 years). The results were analyzed using
paired t tests.
Results: There were no recurrences. There were 4 complications (5.6%): 1 wound infection, 1 case of pneumo-
nia, and 2 persistent air leaks each lasting 1 week. There were no conversions to open surgery. Preoperative and
6-month pulmonary function test results were available on 41 patients, and 35 patients completed 12-month pul-
monary function tests. Twelve-month values (mean percent  SD) were as follows: Forced expiratory volume in
1 second fell from 95 19 to 89 16 (P¼ .02); forced expiratory volume in 1 second/forced vital capacity ratio
was unchanged, 95 12 versus 94 13 (P¼ .9); total lung capacity fell from 106 19 to 98 12 (P¼ 0.002);
vital capacity fell from 100 22 to 96 16 (P¼ .05); residual volume fell from 126 32 to 107 29 (P¼ .002);
and diffusion capacity for carbon monoxide corrected for alveolar volume was unchanged, 88  15 versus
91  17 (P ¼ .07). Flow rates and diffusion capacities were preserved, but lung volumes were slightly reduced
at 1 year.
Conclusions: Video-assisted thoracoscopic apical bullectomy and talc poudrage is an effective treatment
for spontaneous pneumothoraces with a low complication rate and recurrence rate and only minor changes in
pulmonary function at 1 year. (J Thorac Cardiovasc Surg 2010;140:1272-5)Primary spontaneous pneumothorax is a condition that often
affects young, otherwise healthy patients. Operative therapy,
when indicated, requires resection of identifiable blebs and
obliteration of the pleural space. Controversy exists in the
method of pleural obliteration. Most authors perform some
form of mechanical pleurodesis with either pleurectomy or
pleural abrasion. When performed videothoracoscopically,
these approaches are associated with higher recurrence rates
than are open procedures.1 Video-assisted thoracoscopic
(VATS) bullectomy and talc poudrage has emerged as an
effective technique, with a recurrence rate of less than 2%
in the largest study to date.2 Few studies have examined
the effect of talc on lung function,3-5 and no study has
compared preoperative to postoperative lung function after
talc poudrage and bullectomy. In addition, none of these
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The Journal of Thoracic and Cardiovascular Surselected for lung function tests. Some concern remains
regarding the effect of talc on lung function.6 We measured
lung function before and after VATS bullectomy and talc
poudrage in a prospectively enrolled cohort of patients
with spontaneous pneumothoraces. Our objectives were to
determine the effect of talc on short-term lung function and
to assess clinical outcomes. We hypothesized that talc poudr-
age would be effective in preventing recurrences and have
minimal effect on pulmonary function in patients undergoing
apical bullectomies for spontaneous pneumothoraces.METHODS
Patients
From 1999 to 2006, 72 consecutive patients treated with VATS apical
bullectomy and talc poudrage for spontaneous pneumothoraces were pro-
spectively followed up and their information entered into a database ap-
proved The University of Western Ontario ethics review board. Patient
characteristics are shown in Table 1. Indications for surgery included ipsi-
lateral recurrent or bilateral pneumothoraces or persistent air leak despite
chest tube drainage for 7 days. All patients underwent clinical assessment
and chest radiographs at 1, 6, and 12 months postoperatively. Pulmonary
function tests (PFTs) were performed preoperatively and at 6 and 12 months
postoperatively. Pneumothorax recurrence was assessed by chest radio-
graph and defined as any visible pneumothorax as detected by a blinded
radiologist. Preoperative PFTs were compared with 6- and 12-month values
using paired, 2-sided t tests. All PFTs were done at the same laboratory us-
ing a standardized protocol. All results are presented as percent predicted
adjusted for age, gender, height, and race using the European Coal Miners
data set. We report on the results of flow rates (forced expiratory volume in 1gery c December 2010
TABLE 2. Clinical results (n ¼ 72)
No. of patients %
Vanderschueren stage
I (no abnormality) 11 15
II (adhesions) 16 22
III (blebs/bullae<2 cm) 33 46
IV (bullae>2 cm) 12 17
Recurrences (12 mo) 0 0
Complications 4 6
Pneumonia 1
Wound infection 1
Persistent air leaks 2
Conversions to open procedure 0 0
Abbreviations and Acronyms
ARDS ¼ acute respiratory distress syndrome
FEV1 ¼ forced expiratory volume in 1
second
FEV1/FVC ¼ ratio of forced expiratory volume/
forced vital capacity
PFT ¼ pulmonary function test
RV ¼ residual volume
VATS ¼ video-assisted thoracic surgery
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[FEV1/FVC]), lung volumes (total lung capacity, vital capacity, and residual
volume [RV]), and diffusion capacity for carbon monoxide corrected for
alveolar volume.
Operative Technique
All procedures were performed with the patient under general anesthesia
with single lung ventilation. Three thoracoscopic ports were used: one 5-
mm port placed in the seventh intercostal space mid-axillary line, through
which a 5-mm 30 thoracoscope was introduced, one 5-mm port placed
in the fifth intercostal space posterior axillary line, and one 12-mm port
placed in the fifth intercostals space anterior axillary line. The lung was in-
spected for any blebs, bullae, or air leaks during ventilation. Any blebs or
bullae were removed by wedge resection using a 3.53 45-mm (blue) endo-
scopic linear stapler (Ethicon Endosurgery, Cincinnati, Ohio). If no bleb or
bulla was identified, then a minimal apical wedge resection was performed.
Five grams of asbestos-free, sterilized talc (Bryan Corporation, Woburn,
Mass) was nebulized into the pleural cavity. One chest tube was placed in-
traoperatively and removed within 48 hours when there was no an air leak.RESULTS
Clinical Results
All 72 patients completed 12 months of clinical follow-
up. Abnormalities seen at the time of surgery were recorded
according to the Vanderschueren classification7: stage I, no
visible lung abnormality; stage II, pleuropulmonary adhe-
sions; stage III, blebs/bullae less than 2 cm; stage IV, bullae
more than 2 cm. All patients received the same treatment re-
gardless of stage (Table 2). There were no intraoperative
complications and no perioperative deaths. PostoperativeTABLE 1. Patient characteristics
No. of patients %
Total patients 72 100
Age (y) 29 (mean) 15–61 (range)
Male 46 64
Female 26 36
Smokers 35 49
Indication for surgery
Ipsilateral recurrent pneumothorax 58 81
Bilateral pneumothoraces 8 11
Persistent air leak after
chest tube insertion
6 8
The Journal of Thoracic and Carcomplications occurred in 6% of patients (4/72) and in-
cluded 1 case of pneumonia, 1 wound infection, and 2 per-
sistent air leaks, defined as more than 7 days with a chest
tube. All complications resolved without further surgical in-
tervention. There were no conversions to an open procedure.
No recurrent pneumothoraces were detected 12 months after
surgery.PFTs
No patient reported any significant dyspnea during
follow-up. Preoperative and 6-month PFT results were avail-
able on 41 patients and on 35 patients at 12 months. Seven
patients had a chest tube at the time of the preoperative
PFTs. PFTs were analyzed with and without these 7 patients
with no change in the results; thus all patients were grouped
together. There were no significant differences between pa-
tients with 12-month PFTs and patients without 12-month
results; thus the subset of patients with complete 12-month
PFT results is representative of the total group of patients
(Table 3). PFT results are summarized in Table 4. There
was a statistically significant 6% loss of FEV1 (P ¼ .02)
but no change in FEV1/FVC when comparing preoperative
with 12-month values (P ¼ .9). Mean total lung capacity
fell by 8% (P ¼ .002) when comparing preoperative with
12-month values, whereas mean vital capacity and mean
RV fell by 4% (P¼ .05) and 19% (P¼ .002), respectively.
Diffusion capacity remained unchanged, with a change of
þ3% (P¼ .07) when comparing preoperative with 12-month
values. All mean 12-month PFT results were above 88%
predicted.TABLE 3. Comparison of patients with and without 12-month PFTs
Characteristic
Patients
with PFTs
Patients
without PFTs P value
N 37 35
Age (mean, SD) 32 (16) 26 (10) .08
Smokers (%) 17 (46) 18 (51) .64
Male (%) 25 (67) 21 (60) .50
PFT, Pulmonary function test; SD, standard deviation.
diovascular Surgery c Volume 140, Number 6 1273
TABLE 4. Results of pulmonary function tests presented as percent predicted (mean ± standard deviation)
Test Preoperative 6 months 12 months Mean paired difference* P valuey
No. of patients 41 41 35
% FEV1 95  19 90  17 89  16 4.0  8.6 .02
% FEV1/FVC 95  12 78  12 94  13 0.2  8.1 .9
% TLC 106  19 100  16 98  12 8.3  14.7 .002
% VC 100  22 96  15 96  16 4.0  14.2 .05
% RV 126  32 114  42 107  29 19.1  34.7 .002
% DLCO/VA 88  15 87  14 91  17 4.1  8.6 .07
FEV1, Forced expiratory volume in 1 second; FVC, forced vital capacity; TLC, total lung capacity; VC, vital capacity, RV, residual volume; DLCO/VA, diffusion capacity for carbon
monoxide corrected for alveolar volume. *Between preoperative and 12-month pulmonary function tests. yComparing preoperative to 12 months postoperative.
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VATS apical bullectomy and talc poudrage has emerged
as an effective therapy for patients with spontaneous pneu-
mothoraces requiring operative treatment. In our series of
72 patients, we observed no recurrences at 12 months. In
the largest series of 861 patients, Cardillo and associates2 re-
ported a recurrence rate of 1.73% after talc poudrage. These
recurrence rates are lower than those reported for patients
undergoing pleurectomy or abrasion using a minimally inva-
sive approach. In a systematic review comparing open sur-
gery versus VATS for the treatment of spontaneous
pneumothoraces, a 4-fold higher risk of recurrence is seen
after the VATS approach (5.4% vs 1.1%).1 This may be at-
tributed to the difficulty in achieving adequate pleural abra-
sion or pleurectomy during the VATS approach. In
comparison, talc poudrage achieves a low recurrence rate
when performed as a minimally invasive procedure. The ad-
vantages of treating these patients with VATS are reduced
hospital stay and less postoperative pain.8 Critics of the
use of talc cite concerns over the potentially negative effect
on lung function, its possible carcinogenesis, and the risk of
acute respiratory distress syndrome (ARDS).6,9
In our series, we found minimal changes between preop-
erative and 12-month PFT results. Flow rates (FEV1/FVC)
and diffusion capacity (diffusion capacity for carbon mon-
oxide corrected for alveolar volume) were unchanged, al-
though we did see a small decrease in lung volumes at 12
months, mostly owing to a loss of RV. Although statistically
significant, these changes are unlikely to be clinically signif-
icant; all mean values at 12 months were more than 88%
predicted and no patient reported any significant dyspnea
during follow-up, although the long-term effects of talc on
lung function remain uncertain.
Cardillo and associates5 measured long-term lung func-
tion in patients who had undergone either VATS bullectomy
and talc pleurodesis or simple drainage 5 years after surgery.
They found no difference in long-term lung function be-
tween the 2 groups. However, they reported on only 50 of
1065 patients and it is unclear how these patients were se-
lected, inasmuch as they were relatively young compared
with their overall cohort and all were nonsmokers. In another1274 The Journal of Thoracic and Cardiovascular Surstudy of 75 patients treated with talc poudrage for spontane-
ous pneumothoraces, lung function was reported 22 to 35
years after treatment.3 Similar to our study, these authors
found a minor loss of total lung capacity (mean  standard
deviation, 89%  15% vs 96%  12%) when comparing
patients treated with talc poudrage and patients treated
with simple drainage, whereas FEV1 and vital capacity re-
mained unchanged. They also argue that these changes, al-
though statistically significant, are not clinically significant
inasmuch as they did not result in any symptomatic impair-
ment even more than 20 years after treatment. In addition to
the potential effect of talc on lung function, one must con-
sider the effect of the bullectomy itself. In our series, 63%
of patients had visible bullae resected in addition to the
talc poudrage. The reduction in lung volumes, particularly
in RVs, may be due to this resection, although no correlation
existed between the loss of RV and Vanderschueren stage
(Spearman rank correlation 0.02; P ¼ .92). Horio and col-
leagues10 compared PFTs 6 months after surgery between
patients treated with bullectomy alone or bullectomy and
mechanical pleurodesis and found no significant differences
in volumes or flow rates. Although certainly a consideration,
the separate effects of bullectomy and pleurodesis on lung
function may not be clinically relevant inasmuch as most
surgeons perform a combination of both. The other issue
is whether other methods of pleurodesis result in similar
changes to lung function. The mild restrictive changes we
and other authors3 have described after talc pleurodesis
may be due to the pleurodesis itself, regardless of method,
although there is a lack of data to answer this question.
As to the oncologic risk, the use of asbestos-free talc
seems to remove the risk of mesothelioma or lung cancer.
In an older study of 210 patients who had undergone pleu-
rodesis with either talc or kaolin 14 to 40 years before data
collection, Chappel and coworkers11 identified no increase
in rates of lung cancer and no cases of mesothelioma. No
cases were recorded in a study of more than 800 patients
by Cardillo and associates,2 although their mean follow-up
was only 52.5 months. Viskum, Lange, and Mortensen4
did not identify any cases of mesothelioma in 99 patients
treated with talc for spontaneous pneumothoraces with 25gery c December 2010
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literature failed to identify any increased risk of lung cancer
mortality after occupational exposure to asbestos-free talc.12
The risk of ARDS is rare and closely related to the size of
the talc particles used. The majority of cases of ARDS have
been reported in patients treated in the United States, where
most talc preparations have smaller mean particle sizes than
do European preparations.13 Cardillo and associates2 did not
report a single case of ARDs in 861 patients treated with talc.
In a prospective cohort study of 558 patients treated with talc
for malignant pleural effusions, no cases of ARDS were
documented. Authors of this study argue that particle size in-
fluences the risk of ARDS, inasmuch as they used talc of
a controlled particle size with a mean particle size of
24.5 mm and a low percentage of small particles (<10 mm).
This hypothesis is corroborated by animal studies, in which
extrapleural dissemination of talc and lung inflammation
were related to the use of talc with a larger percentage of small
particle sizes (<10mm),14 and that particle size is more impor-
tant than talc dose in causing lung inflammation.15 In a human
study, Maskell and colleagues16 show that use of mixed talc
resulted in more lung and systemic inflammation than did
‘‘graded’’ talc, which had small particles (<10 mm) removed.
There are no data on the optimal dose of talc, with doses rang-
ing from 2 to 10 g.2,17 We used 5 g because 10-g doses have
been linked to cases of ARDS,17,18 whereas other authors
advocate 2-g doses.2,19-21 We did not encounter any cases
of ARDS. The particle size of our talc was not provided by
the manufacturer.
Our study is limited by its short-term follow-up and lack
of a control group. Although all 72 patients did return for
follow-up, a complete set of PFTs was available in only
35 patients. Although all patients agreed to undergo PFTs,
many of them are young university students and it was logis-
tically challenging to bring them into the laboratory to un-
dergo lung function tests. Despite these limitations, our
study is strengthened by its prospective enrollment of con-
secutive patients, blinded outcome assessment, and 100%
clinical follow-up.
In summary, this is the only study comparing prospectively
collected preoperative lung function with postoperative values
in patients treated with VATS apical bullectomy and talc
poudrage. There were no recurrences and only a small loss
in lung volumes, whereas diffusion capacity and flow rates
were maintained at 12 months after surgery. The current
evidence suggests that VATS apical bullectomy and talc
poudrage is safe and effective in the treatment of patients
with pneumothoraces. However, larger prospective studies
with long-term follow-up comparing talc with other formsThe Journal of Thoracic and Carof pleurodesis are needed to settle the controversy surrounding
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